Mechanisms of neurodegeneration in amyotrophic lateral sclerosis

被引:0
|
作者
Cluskey, S [1 ]
Ramsden, DB [1 ]
机构
[1] Univ Birmingham, Queen Elizabeth Hosp, Dept Med, Birmingham B15 2TH, W Midlands, England
来源
关键词
amyotrophic lateral sclerosis; motor neurone disease; neurodegeneration;
D O I
暂无
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Amyotrophic lateral sclerosis (ALS) is the most common variant of motor neurone disease affecting adults that usually strikes during mid to late life. Its aetiology is still poorly understood, although a major breakthrough came with the discovery that mutations in the Cu/Zn superoxide dismutase (SOD1) gene affect approximately 20% of patients with familial ALS. Experiments using both transgenic mice and ALS tissues have been useful in delineating other genetic defects in ALS. However, because only a subset of cases can be attributed to one particular molecular defect (such as mutation of SOD1 or the gene encoding neurofilament H), the aetiology of ALS is likely to be multifactorial. This review discusses the major mechanisms of neurodegeneration in ALS, such as oxidative stress, glutaminergic excitotoxicity, damage to vital organelles, and aberrant protein aggregation.
引用
收藏
页码:386 / 392
页数:7
相关论文
共 50 条
  • [21] Pathological mechanisms of amyotrophic lateral sclerosis
    Hu, Yushu
    Chen, Wenzhi
    Wei, Caihui
    Jiang, Shishi
    Li, Shu
    Wang, Xinxin
    Xu, Renshi
    NEURAL REGENERATION RESEARCH, 2024, 19 (05) : 1036 - 1044
  • [22] Development of neurodegeneration in amyotrophic lateral sclerosis: from up or down?
    F. Geser
    L. Fellner
    J. Haybaeck
    G. K. Wenning
    Journal of Neural Transmission, 2020, 127 : 1097 - 1105
  • [23] RNA-Binding Proteins in Amyotrophic Lateral Sclerosis and Neurodegeneration
    Ugras, Scott E.
    Shorter, James
    NEUROLOGY RESEARCH INTERNATIONAL, 2012, 2012
  • [24] The Regulatory Machinery of Neurodegeneration in In Vitro Models of Amyotrophic Lateral Sclerosis
    Ikiz, Burcin
    Alvarez, Mariano J.
    Re, Diane B.
    Le Verche, Virginia
    Politi, Kristin
    Lotti, Francesco
    Phani, Sudarshan
    Pradhan, Radhika
    Yu, Changhao
    Croft, Gist F.
    Jacquier, Arnaud
    Henderson, Christopher E.
    Califano, Andrea
    Przedborski, Serge
    CELL REPORTS, 2015, 12 (02): : 335 - 345
  • [25] Development of neurodegeneration in amyotrophic lateral sclerosis: from up or down?
    Geser, F.
    Fellner, L.
    Haybaeck, J.
    Wenning, G. K.
    JOURNAL OF NEURAL TRANSMISSION, 2020, 127 (08) : 1097 - 1105
  • [26] Imaging amyotrophic lateral sclerosis (ALS) neurodegeneration through the eye
    Mukherjee, Nisha
    Kuo, Anthony N.
    Bedlack, Richard
    Tseng, Henry
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
  • [27] BIOMARKERS OF NEURODEGENERATION IN CEREBROSPINAL FLUID OF PATIENTS WITH AMYOTROPHIC LATERAL SCLEROSIS
    Gulyaeva, N., V
    Brylev, L., V
    Yakovlev, A. A.
    Nelkina, E. N.
    Zakharova, M. N.
    JOURNAL OF NEUROCHEMISTRY, 2011, 118 : 212 - 213
  • [28] Does interneuronal dysfunction contribute to neurodegeneration in amyotrophic lateral sclerosis?
    Turner, Martin R.
    Kiernan, Matthew C.
    AMYOTROPHIC LATERAL SCLEROSIS, 2012, 13 (03): : 245 - 250
  • [29] AMYOTROPHIC LATERAL SCLEROSIS A role for ubiquilin 2 mutations in neurodegeneration
    Daoud, Hussein
    Rouleau, Guy A.
    NATURE REVIEWS NEUROLOGY, 2011, 7 (11) : 599 - 600
  • [30] Concurrent multiple sclerosis and amyotrophic lateral sclerosis: where inflammation and neurodegeneration meet?
    Grace Li
    Margaret M Esiri
    Olaf Ansorge
    Gabriele C DeLuca
    Journal of Neuroinflammation, 9